FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to biotechnology and medicine, particularly to peptides having Lynx1 protein activity, to a pharmaceutical composition for treating anxiety disorders, depression and correction of cognitive disorders in neurodegenerative diseases containing said peptide, and to a method of treating and correcting said disorders.
EFFECT: disclosed is a peptide having lynx1 protein activity, and a pharmaceutical composition for treating anxiety disorders and depression or correction of cognitive disorders in neurodegenerative diseases containing said peptide.
10 cl, 8 dwg, 5 ex
| Title |
Year |
Author |
Number |
| PEPTIDE HAVING ACTIVITY OF HUMAN SLURP-1 PROTEIN AND ITS APPLICATION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, AND METHOD FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA USING THE SPECIFIED PEPTIDE |
2022 |
- Lyukmanova Ekaterina Nazymovna
- Shenkarev Zakhar Olegovich
- Shulepko Mikhail Anatolevich
- Bychkov Maksim Leonidovich
- Kulbatskii Dmitrii Sergeevich
- Kirpichnikov Mikhail Petrovich
|
RU2792364C1 |
| PEPTIDE ANALOG OF ACYLATED OXYNTOMODULIN |
2018 |
- Che, Iu-Na
- Li, Kajung-Seok
- Che, Yu-Na
- Baek, Gaje-Rim
- Kim, Tae-Khajong
- Yung, Ill-Khun
- Ryu, Che-Lim
- Im, Veon-Bin
|
RU2752787C1 |
| IMPROVED PEPTIDE DRUGS FOR TREATMENT OF NASH AND OTHER DISORDERS |
2019 |
|
RU2790209C2 |
| PEPTIDES AND THEIR USE IN TREATMENT OF DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH MUTANT p53 |
2017 |
- Rotter, Varda
- Oren, Moshe
- Tal, Perry
- Eizenberger, Shay
- Ben-Shimon, Avi
|
RU2762089C2 |
| LONG-ACTING DOUBLE AGONIST OF GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON RECEPTORS |
2021 |
- Yan, Che-Son
- Li, Kyun-Sok
- Chkhe, Yu-Na
- Kim, Te-Khyun
- Chon, Ill-Khun
- Lyu, Chkhe-Lim
- Li, Tkhe-Yun
|
RU2799327C1 |
| PEGILATED BIOLOGICALLY ACTIVE PEPTIDES AND THEIR APPLICATION |
2017 |
|
RU2748576C2 |
| ANTIMICROBIAL PEPTIDE |
2014 |
- Nibbering Petrus Khendrikus
- Khimstra Piter
- Drejfkhaut Yan Vauter
|
RU2695455C2 |
| PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH CONTROL POINT INHIBITING AGENTS FOR TREATING CANCER |
2016 |
|
RU2739201C2 |
| TAU-PEPTIDE IMMUNOGENIC CONSTRUCTS |
2018 |
|
RU2798972C2 |
| TREATMENT OF NEUROLOGICAL DISEASES |
2017 |
|
RU2755997C2 |
